|
ABCL
|
AbCellera Biologics Inc.
|
US
|
NASDAQ
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ATHA
|
Athira Pharma, Inc.
|
US
|
NASDAQ
|
|
AYLA
|
Ayala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AZTA
|
Azenta, Inc.
|
US
|
NASDAQ
|
|
BLTE
|
Belite Bio, Inc.
|
US
|
NASDAQ
|
|
BTAI
|
BioXcel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CDXS
|
Codexis, Inc.
|
US
|
NASDAQ
|
|
CERT
|
Certara, Inc.
|
US
|
NASDAQ
|
|
CLNN
|
Clene Inc.
|
US
|
NASDAQ
|
|
CSBR
|
Champions Oncology, Inc.
|
US
|
NASDAQ
|
|
ENZ
|
Enzo Biochem, Inc.
|
US
|
NYSE
|
|
HSAQ
|
Health Sciences Acquisitions Corporation 2
|
US
|
NASDAQ
|
|
HTGM
|
HTG Molecular Diagnostics, Inc.
|
US
|
NASDAQ
|
|
IMRX
|
Immuneering Corporation
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
LDOS
|
Leidos Holdings, Inc.
|
US
|
NYSE
|
|
ME
|
23andMe Holding Co.
|
US
|
NASDAQ
|
|
MNMD
|
Mind Medicine (MindMed) Inc.
|
US
|
NASDAQ
|